You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 726 to 750 of about 5889
Next 25
03/25/2021
A vaccine targeting mutant IDH1 in newly diagnosed glioma
03/19/2021
Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience
Convection-Enhanced Delivery of a First-in-Class Anti-ß1 Integrin Antibody for the Treatment of High-Grade Glioma Utilizing Real-Time Imaging
03/12/2021
Breaking through the blood brain barrier: Northwestern researchers offer hope for a disease with no cure
03/10/2021
OncoSynergy Announces First Patient Treated in First-in-Human Clinical Trial of OS2966 in Recurrent Glioblastoma
03/08/2021
Compassionate use can save lives!
03/06/2021
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?
03/02/2021
The UCLA Brain Tumor Center will host part two of its Brain Tumor Virtual Conference on Friday, March 12th
02/28/2021
02/21/2021
The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme
02/20/2021
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
02/19/2021
Setting international standards in analyzing patient-reported outcomes and QOL endpoints
02/16/2021
Are you Considering Optune Therapy for GBM?
New zebrafish model could help advance glioblastoma multiforme research
Brain tumor study reveals surprising gene deletion and method to overcome drug resistance
02/15/2021
The effects of releasing early results from ongoing clinical trials
02/12/2021
Sydney researchers identify/advance potential revolutionary new drug treatment for fatal childhood cancer
02/09/2021
New combination treatment approach improves overall survival in mice with glioblastoma
02/06/2021
Amazon Smile Fundraiser! Action Required!
GammaTile webinar posted to our video library!
02/04/2021
Musella Foundation awards two brain tumor research grants!
02/02/2021
First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda
02/01/2021
Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy
01/29/2021
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial
01/27/2021
Imvax Announces Publication of Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma in Clinical Cancer Research